uspto-grants-1979_05
uspto-grants-1979_05 · 10.6084/m9.figshare.5104873.v1 · US04153711
查看条件与参与物IDENTITY
COMPUTED
PROPERTIES
130 °C
Solid
PHARMACOLOGY
Edaravone has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-(5-methyl-2-phenylpyrazol-3-yl)oxyoxane-2-carboxylic acid.;Norantipyrine is a known human metabolite of antipyrine.
Cytoplasm;Extracellular
USES
1H-Pyrazol-5-ol, 3-methyl-1-phenyl-: INACTIVE
ALIASES
REACTIONS
uspto-grants-1979_05
uspto-grants-1979_05 · 10.6084/m9.figshare.5104873.v1 · US04153711
查看条件与参与物uspto-grants-1981_04
uspto-grants-1981_04 · 10.6084/m9.figshare.5104873.v1 · US04260776
查看条件与参与物uspto-grants-1986_07
uspto-grants-1986_07 · 10.6084/m9.figshare.5104873.v1 · US04598020
查看条件与参与物Test data from https://doi.org/10.1039/C8SC04228D
Test data from https://doi.org/10.1039/C8SC04228D · 10.1039/C8SC04228D
查看条件与参与物uspto-grants-1992_04
uspto-grants-1992_04 · 10.6084/m9.figshare.5104873.v1 · US05102781
查看条件与参与物uspto-grants-1992_04
uspto-grants-1992_04 · 10.6084/m9.figshare.5104873.v1 · US05102781
查看条件与参与物uspto-grants-1992_04
uspto-grants-1992_04 · 10.6084/m9.figshare.5104873.v1 · US05102781
查看条件与参与物uspto-grants-1992_04
uspto-grants-1992_04 · 10.6084/m9.figshare.5104873.v1 · US05102781
查看条件与参与物